Published in Int Immunol on November 01, 2000
Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87
How dying cells alert the immune system to danger. Nat Rev Immunol (2008) 8.63
The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med (2002) 4.78
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med (2001) 4.54
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J Exp Med (2011) 4.02
LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev (2008) 3.46
DAMPening inflammation by modulating TLR signalling. Mediators Inflamm (2010) 3.29
The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol (2007) 3.12
HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep (2004) 3.00
The inflammatory response to cell death. Annu Rev Pathol (2008) 2.85
Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J (2009) 2.48
Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease. J Virol (2002) 2.44
MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis. J Exp Med (2003) 2.10
Immunological consequences of apoptotic cell phagocytosis. Am J Pathol (2007) 2.10
Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing. Mol Cell Biol (2008) 1.88
Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci (2009) 1.80
Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa. Cell Stress Chaperones (2010) 1.69
CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J Cell Biol (2002) 1.69
Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J (2003) 1.60
Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol (2004) 1.56
Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells. J Immunol (2004) 1.54
Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc Natl Acad Sci U S A (2003) 1.54
Protective Roles of Natural IgM Antibodies. Front Immunol (2012) 1.48
Stress-induced extracellular Hsp72 is a functionally significant danger signal to the immune system. Cell Stress Chaperones (2003) 1.47
Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med (2005) 1.45
Heat shock proteins: linking danger and pathogen recognition. Med Microbiol Immunol (2007) 1.45
Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol (2009) 1.43
Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-kappaB-dependent mechanism. J Immunol (2007) 1.40
CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns. Trends Immunol (2009) 1.39
Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges. Oncology (Williston Park) (2008) 1.38
The danger theory: 20 years later. Front Immunol (2012) 1.38
Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett (2007) 1.35
Natural endogenous adjuvants. Springer Semin Immunopathol (2004) 1.34
Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J Exp Med (2002) 1.33
CD91-dependent programming of T-helper cell responses following heat shock protein immunization. Nat Commun (2011) 1.32
Caught with their PAMPs down? The extracellular signalling actions of molecular chaperones are not due to microbial contaminants. Cell Stress Chaperones (2010) 1.31
Heat shock response and acute lung injury. Free Radic Biol Med (2006) 1.29
Radiation-induced effects and the immune system in cancer. Front Oncol (2012) 1.27
Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammation. Immunity (2013) 1.26
Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72. J Immunol (2005) 1.26
Stress proteins and initiation of immune response: chaperokine activity of hsp72. Exerc Immunol Rev (2005) 1.24
Immunoregulation of dendritic cells. Clin Med Res (2005) 1.23
Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J Clin Invest (2010) 1.23
Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function. J Immunol (2004) 1.21
Whole tumor antigen vaccines. Semin Immunol (2010) 1.19
Fever therapy revisited. Br J Cancer (2005) 1.16
Chaperonin 60 unfolds its secrets of cellular communication. Cell Stress Chaperones (2002) 1.14
GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression. J Exp Med (2002) 1.13
Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones (2008) 1.13
Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. J Neuroinflammation (2008) 1.11
Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis? Clin Exp Immunol (2011) 1.10
Hyperthermia as an immunotherapy strategy for cancer. Curr Opin Investig Drugs (2009) 1.09
Muscle membrane repair and inflammatory attack in dysferlinopathy. Skelet Muscle (2011) 1.08
Personalized dendritic cell-based tumor immunotherapy. Immunotherapy (2010) 1.08
Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem Biophys Res Commun (2005) 1.07
The expression and functions of toll-like receptors in atherosclerosis. Mediators Inflamm (2010) 1.07
Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? Intensive Care Med (2010) 1.07
Initiation of the Immune Response by Extracellular Hsp72: Chaperokine Activity of Hsp72. Curr Immunol Rev (2006) 1.06
Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells. Proc Natl Acad Sci U S A (2005) 1.05
Facets of heat shock protein 70 show immunotherapeutic potential. Immunology (2003) 1.04
Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO. Immunology (2007) 1.04
Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. Am J Pathol (2007) 1.03
Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity (2010) 1.02
Distinguishing integral and receptor-bound heat shock protein 70 (Hsp70) on the cell surface by Hsp70-specific antibodies. Cell Stress Chaperones (2010) 1.02
Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancies. Cell Stress Chaperones (2009) 1.02
Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury. Am J Physiol Lung Cell Mol Physiol (2006) 1.01
Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells. J Transl Med (2008) 1.00
Heat shock proteins: the fountainhead of innate and adaptive immune responses. Cell Stress Chaperones (2000) 1.00
Identification of gp96 as a novel target for treatment of autoimmune disease in mice. PLoS One (2010) 1.00
Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol (2009) 0.99
An epigenetic vaccine model active in the prevention and treatment of melanoma. J Transl Med (2007) 0.99
Toxoplasma gondii-derived heat shock protein HSP70 functions as a B cell mitogen. Cell Stress Chaperones (2002) 0.99
MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease. Nat Commun (2015) 0.98
Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J Cell Mol Med (2010) 0.98
HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res (2011) 0.97
Innate immune regulation by toll-like receptors in the brain. ISRN Neurol (2012) 0.97
Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation. J Biol Chem (2013) 0.97
Innate immune mechanisms in vitiligo: danger from within. Curr Opin Immunol (2013) 0.97
Intratumoral immunotherapy: using the tumour against itself. Immunology (2005) 0.97
Chaperone proteins and brain tumors: potential targets and possible therapeutics. Neuro Oncol (2005) 0.97
Interaction of serum 70-kDa heat shock protein levels and HspA1B (+1267) gene polymorphism with disease severity in patients with chronic heart failure. Cell Stress Chaperones (2008) 0.96
Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4. Cell Stress Chaperones (2006) 0.96
The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells. Cell Stress Chaperones (2002) 0.96
Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy. Lasers Med Sci (2014) 0.96
The human HSP70 family of chaperones: where do we stand? Cell Stress Chaperones (2016) 0.95
Toll-like receptor 3 signaling enables human esophageal epithelial cells to sense endogenous danger signals released by necrotic cells. Am J Physiol Gastrointest Liver Physiol (2011) 0.95
The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun (2012) 0.95
High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules. Cancer Immun (2010) 0.95
The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity. Front Immunol (2013) 0.94
Inducible heat shock protein 70 reduces T cell responses and stimulatory capacity of monocyte-derived dendritic cells. J Biol Chem (2012) 0.94
The inducible Hsp70 as a marker of tumor immunogenicity. Cell Stress Chaperones (2001) 0.93
Aminoacyl-tRNA synthetase-interacting multifunctional protein 1/p43 controls endoplasmic reticulum retention of heat shock protein gp96: its pathological implications in lupus-like autoimmune diseases. Am J Pathol (2007) 0.93
Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response. Cell Death Differ (2013) 0.93
Calcium signaling in dendritic cells by human or mycobacterial Hsp70 is caused by contamination and is not required for Hsp70-mediated enhancement of cross-presentation. J Biol Chem (2008) 0.92
Quantitative proteomic analysis of single or fractionated radiation-induced proteins in human breast cancer MDA-MB-231 cells. Cell Biosci (2015) 0.92
Heat shock proteins: stimulators of innate and acquired immunity. Biomed Res Int (2013) 0.92
HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo. PLoS Pathog (2013) 0.91
CYLD-mediated signaling and diseases. Curr Drug Targets (2015) 0.91
Mast Cells Respond to Cell Injury through the Recognition of IL-33. Front Immunol (2012) 0.91
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity (2001) 4.16
Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05
CD91: a receptor for heat shock protein gp96. Nat Immunol (2000) 3.78
A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science (1995) 3.58
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med (1993) 2.96
Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci U S A (1986) 2.94
Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science (1997) 2.92
Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model. Biometrics (1992) 2.70
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
Selective retention of dihydrotestosterone by prostatic nuclei. Nature (1968) 2.60
Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med (1997) 2.59
Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A (1990) 2.52
The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA (1991) 2.44
Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity (1998) 2.33
Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med (1988) 2.30
Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J (1993) 2.25
Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc Natl Acad Sci U S A (1994) 2.23
Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA (1992) 2.22
Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol (1991) 2.19
Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J Immunol (1994) 1.98
Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol (1991) 1.91
Receptor proteins for androgens. On the role of specific proteins in selective retention of 17-beta-hydroxy-5-alpha-androstan-3-one by rat ventral prostate in vivo and in vitro. J Biol Chem (1969) 1.74
How reliably can compact chemistry analyzers measure lipids? JAMA (1990) 1.73
Acute renal failure in falciparum malaria--increasing prevalence in some areas of India--a need for awareness. Nephrol Dial Transplant (1996) 1.71
Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J Exp Med (1999) 1.71
Epidemiology of diabetes mellitus in the elderly. The Framingham Study. Am J Med (1986) 1.63
Body fat distribution and breast cancer in the Framingham Study. J Natl Cancer Inst (1990) 1.60
Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int J Cancer (2000) 1.58
Tumor-specific cell surface expression of the-KDEL containing, endoplasmic reticular heat shock protein gp96. Int J Cancer (1996) 1.54
Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham Heart Study). Am J Cardiol (1992) 1.46
Water-clear cell adenoma of the parathyroid. A case report with immunohistochemistry and electron microscopy. Arch Pathol Lab Med (1995) 1.43
Development and quality evaluation of honey based carrot candy. J Food Sci Technol (2011) 1.41
Heart rate adjustment of exercise-induced ST segment depression. Improved risk stratification in the Framingham Offspring Study. Circulation (1991) 1.39
Neuropsychiatric presentations in a case of infective endocarditis. J Assoc Physicians India (1994) 1.39
A national survey of practice patterns in the noninvasive diagnosis of deep venous thrombosis. J Vasc Surg (1999) 1.39
EGFR mutation in gefitinib-responsive small-cell lung cancer. Ann Oncol (2005) 1.38
Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas. Cancer Res (1987) 1.38
Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules. J Biol Chem (2001) 1.37
Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer (1999) 1.37
Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J Immunol (1999) 1.36
Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol (1994) 1.36
Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes (1992) 1.36
Heat shock protein vaccines against cancer. J Immunother Emphasis Tumor Immunol (1993) 1.35
Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J Immunol (2000) 1.34
Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience). Am J Cardiol (1991) 1.32
Risk of coronary heart disease in subjects with chest discomfort: the Framingham Heart Study. Am J Med (1990) 1.29
Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry (1988) 1.28
Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol (1992) 1.28
BMP-2 gene expression and effects on human vascular smooth muscle cells. J Vasc Res (1999) 1.28
The dual nature of specific immunological activity of tumor-derived gp96 preparations. J Exp Med (1999) 1.27
The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein. Proc Natl Acad Sci U S A (2001) 1.27
Identification and characterization of cvHsp. A novel human small stress protein selectively expressed in cardiovascular and insulin-sensitive tissues. J Biol Chem (1999) 1.26
Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relationship to stress-induced proteins. Proc Natl Acad Sci U S A (1990) 1.26
Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J (1990) 1.24
Individually distinct transplantation antigens of chemically induced mouse tumors. Immunol Today (1988) 1.24
Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study. Am J Med (1991) 1.22
A new method for indexing left ventricular mass for differences in body size. Am J Cardiol (1994) 1.21
Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 1.21
Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells. J Immunol (2000) 1.19
Impact of national guidelines for cholesterol risk factor screening. The Framingham Offspring Study. JAMA (1989) 1.17
Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography. J Immunol Methods (1997) 1.16
The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen. Int J Cancer (1984) 1.14
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol (1992) 1.13
Case report. Orbital metastasis from gall bladder carcinoma. Br J Radiol (2002) 1.11
5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors. Proc Natl Acad Sci U S A (1987) 1.10
Is there a relationship between exercise systolic blood pressure response and left ventricular mass? The Framingham Heart Study. Ann Intern Med (1992) 1.10
The Forkhead factor FoxQ1 influences epithelial differentiation. J Cell Physiol (2011) 1.08
Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease. Proc Natl Acad Sci U S A (1991) 1.08
Molecular heterogeneity of tumor rejection antigen/heat shock protein GP96. Int J Cancer (1995) 1.07
Active tuberculosis after isoniazid chemoprophylaxis of Southeast Asian refugees. Am Rev Respir Dis (1986) 1.06
The endoplasmic reticular heat shock protein gp96 is transcriptionally upregulated in interferon-treated cells. J Exp Med (1994) 1.05
Assessment of autonomic dysfunction in Guillain-Barré syndrome and its prognostic implications. Acta Neurol Scand (1987) 1.05
Fetal translocation and metabolism of PAH obtained from coal fly ash given intratracheally to pregnant rats. J Toxicol Environ Health (1986) 1.05
Spectrum of renal cortical necrosis in acute renal failure in eastern India. Postgrad Med J (1995) 1.04
Anti-human RP105 sera induces lymphocyte proliferation. J Leukoc Biol (1999) 1.02
Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96. J Immunother (1998) 1.01
Physical activity and risk of large bowel cancer in the Framingham Study. Cancer Res (1990) 1.00
Heat, heat shock, heat shock proteins and death: a central link in innate and adaptive immune responses. Immunol Lett (2000) 1.00
Effect of soy protein isolate incorporation on quality characteristics and shelf-life of buffalo meat emulsion sausage. J Food Sci Technol (2010) 1.00
Heat shock proteins: the fountainhead of innate and adaptive immune responses. Cell Stress Chaperones (2000) 1.00
Acute renal failure in eastern India. Nephrol Dial Transplant (1995) 0.98
Heat shock protein--peptide complexes as immunotherapy for human cancer. Mol Med Today (1998) 0.97
Lipids, glucose intolerance and vascular disease: the Framingham Study. Monogr Atheroscler (1985) 0.97
Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors. Semin Cancer Biol (1995) 0.97
Surgery for abdominal aortic aneurysms associated with malignancy. Surg Today (1998) 0.96
Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. Biochemistry (1989) 0.95
Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem (1989) 0.94
T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity. J Exp Med (1995) 0.93
CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection. J Exp Med (1991) 0.93
Risk factors and outcomes following revascularization for chronic mesenteric ischemia. Ann Vasc Surg (1999) 0.92